We are live on
!
Find out more
CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Est. Return
64.75%
This Fund
S&P 500
This Quarter
Est. Return
+8.98%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.4M
AUM Growth
–
Cap. Flow
+$8.48B
Cap. Flow
% of AUM
90,213.08%
Top 10 Holdings %
Top 10 Hldgs %
19.15%
Holding
297
New
297
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$210M |
| 2 |
WCN
Waste Connections
WCN
|
+$143M |
| 3 |
IPG Photonics
IPGP
|
+$133M |
| 4 |
Cognex
CGNX
|
+$127M |
| 5 |
PTC
PTC
|
+$117M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.41% |
| 2 | Technology | 19.12% |
| 3 | Industrials | 15.58% |
| 4 | Consumer Discretionary | 12.66% |
| 5 | Financials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXDX
76
DELISTED
Ignyta, Inc.
RXDX
| $41.8K | 0.44% |
+1,564,814
| New | +$25.4M |
|
|
SRG
77
Seritage Growth Properties
SRG
$130M
| $41.8K | 0.44% |
+1,032,564
| New | +$43.1M |
|
78
NVIDIA
NVDA
$5.01T
| $41.6K | 0.44% |
+8,595,600
| New | +$42.7M |
|
|
SF
79
Stifel
SF
$12.3B
| $41K | 0.44% |
+1,550,540
| New | +$37.9M |
|
|
XLRN
80
DELISTED
Acceleron Pharma
XLRN
| $40K | 0.43% |
+942,844
| New | +$35.4M |
|
81
West Pharmaceutical
WST
$23.1B
| $39K | 0.42% |
+395,622
| New | +$38.8M |
|
82
Manhattan Associates
MANH
$8.97B
| $38.9K | 0.41% |
+785,826
| New | +$35.3M |
|
83
Idexx Laboratories
IDXX
$42.9B
| $38.8K | 0.41% |
+248,386
| New | +$39.1M |
|
84
Woodward
WWD
$25B
| $38.8K | 0.41% |
+507,148
| New | +$39.6M |
|
85
Sarepta Therapeutics
SRPT
$1.66B
| $38.7K | 0.41% |
+695,904
| New | +$36.9M |
|
86
Omnicell
OMCL
$1.86B
| $38.6K | 0.41% |
+796,115
| New | +$40.2M |
|
87
Sensient Technologies
SXT
$5.4B
| $38.2K | 0.41% |
+521,716
| New | +$39.8M |
|
88
Encompass Health
EHC
$11.2B
| $38K | 0.4% |
+966,316
| New | +$36.8M |
|
89
MGM Resorts International
MGM
$11.7B
| $37.5K | 0.4% |
+1,124,256
| New | +$36.2M |
|
90
Edwards Lifesciences
EW
$47.6B
| $37.3K | 0.4% |
+992,832
| New | +$36.4M |
|
|
PRA
91
DELISTED
ProAssurance
PRA
| $37.3K | 0.4% |
+652,523
| New | +$38.1M |
|
|
IMPV
92
DELISTED
Imperva, Inc.
IMPV
| $36.8K | 0.39% |
+927,014
| New | +$38.6M |
|
93
Micron Technology
MU
$1.04T
| $36.7K | 0.39% |
+891,936
| New | +$38.4M |
|
|
THR
94
DELISTED
Thermon Group Holdings
THR
| $36.1K | 0.38% |
+1,524,958
| New | +$33.3M |
|
95
United Rentals
URI
$71.1B
| $36.1K | 0.38% |
+209,947
| New | +$32M |
|
|
CAVM
96
DELISTED
Cavium, Inc.
CAVM
| $36K | 0.38% |
+429,811
| New | +$33.3M |
|
|
MDSO
97
DELISTED
Medidata Solutions, Inc.
MDSO
| $35.2K | 0.37% |
+554,903
| New | +$39.5M |
|
|
SPLK
98
DELISTED
Splunk Inc
SPLK
| $34.1K | 0.36% |
+411,964
| New | +$30.2M |
|
99
HealthEquity
HQY
$7.91B
| $34.1K | 0.36% |
+730,811
| New | +$36.2M |
|
100
Penumbra
PEN
$12.5B
| $34K | 0.36% |
+361,292
| New | +$35.8M |
|
Similar funds
GAM
CCI
SWM
LCM
HCMNY
BII
HCM
DBC
Carillon Tower Advisers's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Carillon Tower Advisers, which disclosed 297 positions worth $9.4M. Its ten largest holdings account for 19% of the portfolio.
Its largest position is Coherent Inc: 755,170 shares worth $213K.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Technology and Industrials.
- Carillon Tower Advisers's largest Q4 2017 buy was Coherent Inc: 755,170 shares worth $213K.
- Carillon Tower Advisers's ten largest holdings make up 19% of its $9.4M portfolio in Q4 2017.
- Carillon Tower Advisers disclosed 297 positions in Q4 2017, its first 13F filing on record.
Based on Carillon Tower Advisers's 13F filing for Q4 2017, filed 12 Feb 2018.